3Strata Technologies, a new software company, today officially announced the launch of its first application Inca Clinic. Inca Clinic, a complete travel vaccination application, has been developed to assist doctors and other medical practitioners in managing the increasing demand on travel vaccination clinics.
Sean Baker, Chairman and Richard Boyd, CEO, 3Strata Technologies at the launch of Inca Clinic
The World Tourism Organization predicts that by 2020, over 375 million people a year will travel to long-haul destinations with 125 million of those travelling to ‘at risk’ destinations. An ‘at risk’ destination means there is a greater risk to the traveller of contracting diseases such as Typhoid, Hepatitis A, Yellow Fever or Malaria. To protect themselves, travellers visit their local travel vaccination clinic to get their vaccines, other medication and related medical advice.
Inca Clinic has been devised to simplify the complexity of creating, managing and integrating a patient’s travel itinerary, vaccine schedule, medication and related health information. The application also takes care of stock control, batch number management and vaccine administration.
Inca Clinic enables travel vaccination clinics to become more efficient, profitable and better connected to their customers. It is delivered to clients using a Software-as-a-Service (SaaS) model which reduces costs and the need for IT skills within travel vaccination clinics.
3Strata Technologies, which is headquartered in NovaUCD, the Innovation and Technology Transfer Centre, was established in 2010. The company was co-founded by Richard Boyd, a former director of the Executive Medical Care Ltd (EMC) which runs the Tropical Medical Bureau (TMB), and Sean Baker, co-founder of IONA Technologies.
Richard Boyd, CEO, 3Strata Technologies, said, “Our aim is provide medics, travellers and pharmaceutical companies with the software, support and information they need to reduce the health-related risks for people travelling to at risk destinations. Our vision is to achieve this by using software applications to interconnect all stakeholders in the travel vaccine market. Inca Clinic is the first in a series of applications we intend to launch to achieve this interconnection.” He added, “We already have a number of customers using Inca Clinic in New Zealand and the UK and we hope to be signing up other new clients in the near future.”
As Inca Clinic is provided to clinics using a centralised internet service, travellers will soon be able to access their travel vaccine itineraries and other vital health information using 3Strata’s next application, Inca Traveller. Inca Traveller, which will be accessible via social media and mobile applications, will provide travellers with vaccine reminders and news alerts, and will also enable travellers to communicate with their clinic more easily while they travel.
According to Sean Baker, Chairman, 3Strata Technologies, “3Strata is taking a new approach to providing software in the healthcare space. Each of the family of products addresses the needs of one set of users but the applications work together to integrate the entire travel vaccine market. Combined they do something very special.”
Inca Clinic and Traveller will together build a rich repository of data that can then be used to develop a third application, Inca Data Services, to provide market data and aid clinic trials for the pharmaceutical industry.
3Strata Technologies has raised seed funding in May 2010 from Enterprise Ireland, the promoters and private investors.
ENDS
6 October 2011
For further information contact: Micéal Whelan, NovaUCD, t: +353 1 716 3712, e: miceal.whelan@ucd.ie or Richard Boyd, 3Strata Technologies, t: +353 87 295 8788, e: richard.boyd@3strata.com
Editors Notes
3Strata Technologies provides medics and travellers with the information and support that they need to reduce the dangers of travelling to ‘at risk’ destinations. www.3strata.com
For additional World Tourism Organization ‘facts and figures’ visit www.unwto.org/facts/menu.html
NovaUCD, the Innovation and Technology Transfer Centre, is the hub of innovation and knowledge transfer activities at University College Dublin. NovaUCD is responsible for the commercialisation of intellectual property arising from UCD research and for the development of co-operation with industry and business. NovaUCD as a purpose-built centre also nurtures new technology and knowledge-intensive enterprises such as 3Strata Technologies. NovaUCD has been funded through a unique public-private partnership that includes AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, UCD and Xilinx. www.ucd.ie/nova